Cargando...

The innovative development in interferon beta treatments of relapsing‐remitting multiple sclerosis

The introduction of interferon beta therapies more than 20 years ago marked a milestone in the treatment of relapsing‐remitting multiple sclerosis (RRMS) with a significant impact on the approach to modern multiple sclerosis (MS) care. Key learnings and perspectives from the early days of disease mo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Brain Behav
Autor principal: Madsen, Claus
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5474703/
https://ncbi.nlm.nih.gov/pubmed/28638705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.696
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!